BCL2 and hepatocellular carcinoma: In hepatocellular carcinoma (HCC), for example, this miRNA negatively regulates SPOCK1 gene expression, indirectly disrupting the dynamic equilibrium of BCL-2 family proteins and impairing the activation of the p53 signaling pathway, ultimately enhancing tumor cell resistance to apoptotic signals (21).